| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Panbela Therapeutics, Inc. | President and CEO, Director | Stock Option (right to buy) | 72.8K | Oct 1, 2024 | Direct | ||
| EAGLE PHARMACEUTICALS, INC. | Director | Stock Option (right to buy) | 16.3K | Mar 7, 2023 | Direct | ||
| LadRx Corp | Director | Stock Option (Right to Buy) | 5K | Jan 15, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| PBLA | Panbela Therapeutics, Inc. | Oct 1, 2024 | 1 | $0 | 4 | Oct 3, 2024 | President and CEO, Director |
| LADX | LadRx Corp | Jan 15, 2024 | 1 | $0 | 4 | Jan 29, 2024 | Director |
| PBLA | Panbela Therapeutics, Inc. | Mar 27, 2023 | 1 | $0 | 4 | Mar 29, 2023 | President and CEO, Director |
| EGRX | EAGLE PHARMACEUTICALS, INC. | Mar 7, 2023 | 1 | $0 | 4 | Mar 9, 2023 | Director |
| PBLA | Panbela Therapeutics, Inc. | Jan 30, 2023 | 2 | $0 | 4 | Feb 1, 2023 | President and CEO, Director |
| EGRX | EAGLE PHARMACEUTICALS, INC. | Feb 28, 2022 | 1 | $0 | 4 | Mar 2, 2022 | Director |
| LADX | CYTRX CORP | Dec 15, 2021 | 1 | $0 | 4/A | Jan 11, 2022 | Director |
| LADX | CYTRX CORP | Dec 15, 2021 | 1 | $0 | 4 | Dec 17, 2021 | Director |
| PBLA | Panbela Therapeutics, Inc. | Sep 13, 2021 | 1 | $0 | 4 | Sep 15, 2021 | President and CEO, Director |
| LADX | CYTRX CORP | Jul 29, 2021 | 0 | $0 | 3 | Aug 11, 2021 | Director |